Sens. Kelly, Tillis Introduce Bipartisan Legislation to Increase Access to Plasma-Based Medicines
July 25, 2024
July 25, 2024
WASHINGTON, July 25 -- Sen. Mark Kelly, D-Arizona, issued the following news release on July 24, 2024:
Today, Senators Mark Kelly (D-AZ) and Thom Tillis (R-NC) introduced the bipartisan Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act, legislation to ensure individuals with rare diseases and immunodeficiencies have access to necessary plasma-based medicines.
"Ensuring that individuals with rare diseases and immunodeficiencies have acces . . .
Today, Senators Mark Kelly (D-AZ) and Thom Tillis (R-NC) introduced the bipartisan Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act, legislation to ensure individuals with rare diseases and immunodeficiencies have access to necessary plasma-based medicines.
"Ensuring that individuals with rare diseases and immunodeficiencies have acces . . .